GSK3B and cancer: Recently, Liu et al. confirmed that AKT activation suppresses the activity of GSK3β and stabilizes Nrf2, which decreasing sensitivity to ferroptosis in the isocitrate dehydrogenase gene-mutated cancer cells [50].